IL10 and hepatocellular carcinoma: Among these factors, transforming growth factor (TGF)-β and IL-10 are key players in HCC pathogenesis, where dysregulated TGF-β signaling pathways promote persistent liver inflammation, fibrogenesis, and TME immunomodulation [21].